People affected by hepatitis C Virus (HCV) are enthusiastic about long-acting cure research, according to surveys in low- and middle-income countries by the Unitaid-funded LONGEVITY Project (of which TAG is a member). Read our statement on the findings: https://www.treatmentactiongroup.org/statement/community-surveys-show-enthusiasm-for-long-acting-hcv-cure-research/